Literature DB >> 2714422

Tissue iron deposition in untransfused beta-thalassemic mice.

L M Garrick1, L A Strano-Paul, J E Hoke, L A Kirdani-Ryan, R A Alberico, M M Everett, R M Bannerman, M D Garrick.   

Abstract

Homozygous beta-thalassemic mice show many of the features seen in human beta-thalassemia, such as decreased hemoglobin, hematocrit, and red blood cell count as well as increased reticulocyte count. They also exhibit splenomegaly and a decrease in osmotic fragility of red cells. beta-thalassemic mice were examined for spontaneous iron overload at ages ranging from 20 to 595 days. Accumulation of iron was shown to occur in the spleen, liver, and kidneys but not in the heart. Sections of spleen, liver, kidney, and heart were stained for iron and subjectively scored. Image analysis microscopy was used to examine sections of spleen and liver. Nonheme iron in the four tissues was quantitated using the bathophenanthroline sulfonate colorimetric assay. An increase in tissue iron occurred primarily in the spleen, even before weaning, despite the low iron content of milk. Iron accumulation in the absence of blood transfusion is of interest because iron overload is the major cause of death in human beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714422

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Selective erythroid replacement in murine beta-thalassemia using fetal hematopoietic stem cells.

Authors:  C A Bethel; D Murugesh; M R Harrison; N Mohandas; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 2.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

3.  Transferrin therapy ameliorates disease in beta-thalassemic mice.

Authors:  Huihui Li; Anne C Rybicki; Sandra M Suzuka; Leni von Bonsdorff; William Breuer; Charles B Hall; Z Ioav Cabantchik; Eric E Bouhassira; Mary E Fabry; Yelena Z Ginzburg
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

4.  A mouse model for beta 0-thalassemia.

Authors:  B Yang; S Kirby; J Lewis; P J Detloff; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 5.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.